Even though price reduction cards can help reduce the load of superior drug fees in the temporary, they do not address the systemic issues driving up prescription selling prices in the U.S. Broader plan adjustments could tackle the foundation will cause of mounting drug selling prices, which include deficiency of transparency in pricing along with